SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-002494
Filing Date
2020-02-14
Accepted
2020-02-14 16:06:16
Documents
54
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 471097
2 ex31-1.htm EX-31.1 35792
3 ex32-1.htm EX-32.1 12644
  Complete submission text file 0001493152-20-002494.txt   2646700

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE vbio-20191231.xml EX-101.INS 379239
5 XBRL SCHEMA FILE vbio-20191231.xsd EX-101.SCH 40296
6 XBRL CALCULATION FILE vbio-20191231_cal.xml EX-101.CAL 45223
7 XBRL DEFINITION FILE vbio-20191231_def.xml EX-101.DEF 103133
8 XBRL LABEL FILE vbio-20191231_lab.xml EX-101.LAB 277812
9 XBRL PRESENTATION FILE vbio-20191231_pre.xml EX-101.PRE 196282
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 20619489
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services